Company profile
ONtrack Biomedical AG
ONtrack Diagnostics is a medtech company focusing on the development of non-invasive assays for the screening, diagnosis and monitoring of oncological diseases. Our first product is a urine assay for the screening of prostate cancer.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
